Clinical Trial: To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07120308) titled 'To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis' on Sept. 16, 2021.

Brief Summary: An investigator-initiated single-center, randomized, double-blind, placebo-controlled clinical study .The main purpose is to evaluate the effectiveness of ZKY001 eye drops in treating corneal epithelial defects caused by neurotrophic keratitis in patients.

Study Start Date: Sept. 15, 2021

Study Type: INTERVENTIONAL

Condition: Corneal Epithelial Defect

Intervention: DRUG: ZKY001 eye drops

Administer to eyes

DRUG: Vehicle (placebo)

Administer to eyes

Recrui...